This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1989:76:106-10; discussion 110-1.

doi: 10.1159/000417886.

Single-dose kinetics of recombinant human erythropoietin after intravenous, subcutaneous and intraperitoneal administration. Preliminary results

D Kampf¹, A Kahl, J Passlick, A Pustelnik, K U Eckardt, B Ehmer, C Jacobs, A Baumelou, B Grabensee, G M Gahl

Affiliations

PMID: 2582776
DOI: 10.1159/000417886

Comparative Study

Single-dose kinetics of recombinant human erythropoietin after intravenous, subcutaneous and intraperitoneal administration. Preliminary results

D Kampf et al. Contrib Nephrol. 1989.

. 1989:76:106-10; discussion 110-1.

doi: 10.1159/000417886.

Authors

D Kampf¹, A Kahl, J Passlick, A Pustelnik, K U Eckardt, B Ehmer, C Jacobs, A Baumelou, B Grabensee, G M Gahl

Affiliation

¹ Nephrologische Abteilung, Universitätsklinik Rudolf Virchow/Charlottenburg, Berlin.

PMID: 2582776
DOI: 10.1159/000417886

No abstract available

PubMed Disclaimer

Similar articles

Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatment.
Macdougall IC, Roberts DE, Neubert P, Dharmasena AD, Coles GA, Williams JD. Macdougall IC, et al. Contrib Nephrol. 1989;76:112-20; discussion 120-1. doi: 10.1159/000417887. Contrib Nephrol. 1989. PMID: 2684515 Clinical Trial. No abstract available.
Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Macdougall IC, Roberts DE, Neubert P, Dharmasena AD, Coles GA, Williams JD. Macdougall IC, et al. Lancet. 1989 Feb 25;1(8635):425-7. doi: 10.1016/s0140-6736(89)90014-7. Lancet. 1989. PMID: 2563798
Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure.
Braun A, Ding R, Seidel C, Fies T, Kurtz A, Schärer K. Braun A, et al. Pediatr Nephrol. 1993 Feb;7(1):61-4. doi: 10.1007/BF00861571. Pediatr Nephrol. 1993. PMID: 8439481
Starting r-HuEPO in chronic renal failure: when, why, and how?
Koene RA, Frenken LA. Koene RA, et al. Nephrol Dial Transplant. 1995;10 Suppl 2:35-42. doi: 10.1093/ndt/10.supp2.35. Nephrol Dial Transplant. 1995. PMID: 7644104 Review. No abstract available.
Controversies in selection of epoetin dosages. Issues and answers.
Zachée P. Zachée P. Drugs. 1995 Apr;49(4):536-47. doi: 10.2165/00003495-199549040-00004. Drugs. 1995. PMID: 7789287 Review.

See all similar articles

Cited by

Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
Pérez-Oliva JF, Casanova-González M, García-García I, Porrero-Martín PJ, Valenzuela-Silva CM, Hernández-Montero T, Lagarde-Ampudia M, Casanova-Kutsareva Y, Avila-Albuerne Y, Vargas-Batista A, Bobillo-López H, Herrera-Valdés R, López-Saura PA; Bioequivalence Study of Erythropoietin Group. Pérez-Oliva JF, et al. BMC Nephrol. 2005 May 23;6:5. doi: 10.1186/1471-2369-6-5. BMC Nephrol. 2005. PMID: 15910687 Free PMC article. Clinical Trial.
Subcutaneous r-HuEPO therapy in CAPD patients: dose determination and clinical experience.
Janicka L, Ksiazek A, Baranowicz I, Bednarek-Skublewska A, Mierzicki P, Ksiazek P. Janicka L, et al. Int Urol Nephrol. 1998;30(1):91-7. doi: 10.1007/BF02550285. Int Urol Nephrol. 1998. PMID: 9569119 Clinical Trial.
The pharmacokinetics of recombinant human erythropoietin after subcutaneous injection at different sites.
Jensen JD, Jensen LW, Madsen JK. Jensen JD, et al. Eur J Clin Pharmacol. 1994;46(4):333-7. doi: 10.1007/BF00194401. Eur J Clin Pharmacol. 1994. PMID: 7957518
The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients.
Brockmöller J, Köchling J, Weber W, Looby M, Roots I, Neumayer HH. Brockmöller J, et al. Br J Clin Pharmacol. 1992 Dec;34(6):499-508. Br J Clin Pharmacol. 1992. PMID: 1493082 Free PMC article.
Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.
Doshi S, Krzyzanski W, Yue S, Elliott S, Chow A, Pérez-Ruixo JJ. Doshi S, et al. Clin Pharmacokinet. 2013 Dec;52(12):1063-83. doi: 10.1007/s40262-013-0098-x. Clin Pharmacokinet. 2013. PMID: 23912564 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland